University of Michigan, Ann Arbor) (Received for publication March 13, 1948) It has been shown that repeated inoculation of immune animals (1, 2) does not ordinarily result in significant increases in antibody titer to the homologous strain but that when immunity declines a second inoculation may serve to increase the serum antibody titers well above the level reached after a primary infection. In contrast to normal experimental animals, the common experience with man has been that the antibody response to influenza virus reaches its height after a single inoculation of virus and that repeated inoculations within short intervals do not result in higher levels. Moreover, the accumulated data give little evidence of an exaggerated antibody response to a second stimulus administered after an interval of several months when antibody titers may be declining. It has been repeatedly suggested that the difference observed in the behavior of man and experimental animals is related to the fact that the former usually has already acquired antibody as a result of experience with the disease while the latter is a normal, inexperienced individual. In man the antigenic stimulus is presumed to be limited by the presence of antibody previously acquired (3, 4) .
Early in the studies of the development of antibodies to different strains of influenza virus it was demonstrated in ferrets that repeated inoculations of the PR8 strain could result in the production of antibodies to a strain of swine influenza virus (5) . This broadening in the antibody pattern with multiple injections was subsequently noted when rabbits, or mice were employed (5 to 8).
It was of interest, then, to consider whether infants and young children, who had been sub- ' jected to little or no exposure to influenza, when given repeated injections of influenza virus vaccine would exhibit a broadening in antibody coverage against antigenically different strains even though the height of response to the homologous strain was little changed. The present report comprises results of a study undertaken to answer this question.
There was no evidence that influenza A had been prevalent in Michigan since the winter of 1943-44. Hence a group of young human individuals with average age of 3.2 years and largely without antibody to selected strains of influenza virus was chosen for the study.
MATERIALS AND METHODS

Subjects
The children were from the Sarah Children with allergic tendencies were omitted from the study groups. It is worth noting that eggs represented a substantial portion of the diet and any egg sensitization probably would have become readily evident a short time after entering the home. During the course of the study an occasional child missed a scheduled dose of vaccine because of illness, discharge from institution or other reason.
There had been no previous program of vaccination with influenza virus at the home. However, concurrent with the outbreak of type B influenza in the winter of 1945-46 in this area (9, 10) 
RESULTS
It was first noted that the prevaccination titers of the individual sera from the three groups followed a definite age pattern when the tests against the PR8 strain were analyzed. Only one of 54 children under four years of age had a serum antibody level greater than 32 (Table III) . Con (Table  VI) . In calculating the means all sera with titers of less than 32 were assigned the value of 16 . This reduced the mean prevaccination titers and masked those individuals in the groups who had high initial titers. However, these latter sera are demonstrated in the figures showing the distribution of titers in the three groups. Also there are differences in the numbers of individuals who are included in some of the tables. This is occasioned in one instance by the fact that accurate ages were not obtainable; consequently they could not be assigned properly in the tables where age is an important factor. Some sera became contaminated and could not be titrated. The prevaccination titers against the Baum strain were so high, owing to non-specific inhibition, that the results with that antigen were not included in the selected data. Such factors contribute to the slight variations in tabulated data.
The findings summarized in the tables demonstrate that repeated inoculations within limited time intervals, regardless of dosage, resulted in cumulative increases in antibody titer (Table IV and Figures 1 to 3 ). This fact is not in keeping with effects commonly noted in adult humans, but approaches more that observed in experimental animals. Whether or not these differences are significant can not be definitely stated when the data are viewed only in Table IV where the mean titers of the entire groups are presented. However, as seen in Table V where the mean titers of selected groups are given, the differences follow the same trend observed in Table IV in children between the ages of one and three and a half years; and (d) where the effect was measurable the use of more than three doses contributed no significant advantages to antibody production.
The above results for the homologous strain were paralleled by the other type A strains tested. The efficiency of multiple injections of the PR8 strain in inducing antibody response to heterologous strains was fairly good with other type A strains and the degree of response appeared to vary with the test strain. Antibody response against two swine strains was meager. However, higher mean levels of antibody to all the strains studied were associated with multiple injections of the PR8 strain except in the children of four years or more who received the large doses; in these instances, the complete effect was obtained with one injection.
Other reports of the antibody response to influenza virus vaccine (3, 16 to 21) have indicated that maximum titers occur with a single injection of vaccine and that further injections did not increase the height of the titer. However, most of these studies were conducted in older subjects.
It should be pointed out that the interval between the second and third bleedings in Group I was 27 days and that the third bleeding was six weeks after the first dose of vaccine. It is possible that the results obtained in the third bleeding represent continued rise associated with stimulating effect caused by the initial injection. In some individuals, however, no increase in titer was observed two weeks after the first dose suggesting that the subsequent rise in their titers was related to the additional inoculations. This effect of delayed rising of titers was noted more strikingly in Group II. Nevertheless, the data here do not permit a precise conclusion. Further investigation of the time relation of antibody formation in infants and children must be done to clarify this point. The rises in titer against the heterologous type A strains can be postulated as being due to common antigenic characteristics.
The close agreement in mean response of all groups when tested against the PR8 and Weiss strains points to the use of only one of these strains in a vaccine. Recent experience with an outbreak of type A influenza virus infection in the late winter and spring of 1947 (22 to 24) indicates that stimulate the formation of antibodies against the new strains when a single subcutaneous injection of vaccine was given. Accordingly, the sera of the selected members from Group I were tested against a strain of type A virus isolated in the early 1947 epidemic (Rhodes). Sera from five of the 19 individuals tested had no rise in antibodies between the prevaccination bleeding and the bleeding taken two weeks after the last dose; four had two-fold rises, and 10 had four-fold or greater rises in titer. However, the highest titers reached wete only 512 in four instances. The remainder were 256 or less. Thus repeated vaccinations with the PR8 strain did result in the development of antibodies to the 1947 strain in some of the children.
Other than antigenic specificity, the relation of dose, number of injections, and interval between injections requires some further consideration.
It is apparent, from the presented data, that maximal antibody response in children does not always occur with a single injection of vaccine. Despite the fact that a maximal dose, in terms of reactions to the vaccine, was given to the children in Group I, subsequent injections caused a further elevation in titer. This finding was most pronounced in the children under four years of age (Table VI) .
The amount of vaccine in the first dose was roughly equivalent to 1 ml. of infected allantoic fluid. The later injections approximated 0.65 ml. of allantoic fluid. With two more injections of the latter amount significant rises occurred in the mean titers against all type A strains tested. De- creasing the dosage to a concentration equivalent to 0.15 ml. of infected allantoic fluid, as in Groups II and III, gave lower mean antibody titers. However, using such a small dose the antibody response was greater than anticipated. The results of the Group III study, where the small amount of vaccine was given every other day for five days, showed a better mean titer than when given over the longer period of time as in Group II. As noted earlier the probable optimal dose and interval between doses lies somewhere between the effects noted in Groups I and III, also the use of more than three injections of vaccine did not contribute any significant changes. A reasonable schedule would seem to be the use of three injections of the equivalent of 0.3 ml. of infected unconcentrated allantoic fluid spaced at weekly intervals. The use of concentrated material in infants and young children is not advisable unless the vaccine preparation is diluted prior to use.
SUMMARY
Multiple subcutaneous injections in children, whose average age was 3.2 years, ofan influenza virus vaccine containing the type A PR8 strain, gave greater rises in mean titer of erythrocyte agglutination-inhibiting antibody against the homologous strain than did a single injection of the same virus preparation. In children of four years of age or older, who were living at the time of the last previous epidemic of influenza A in the area, the maximal response was obtained after a single large dose. Rises in titer to three other type A strains tested also occurred. Rises in titer to two strains of swine influenza virus were less pronounced. The height of antibody response to the heterologous strains was apparently influenced by the intimacy of their antigenic relationship to the PR8 strain and was not progressively enhanced as the administration of vaccine was continued beyond three doses.
The significance of the antigenic variation of strains, dosage, and schedule of injections of influenza virus vaccine in children is discussed.
